Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc | |
| 9/20/2021 | $17.00 | Overweight | Keybanc |
| 7/9/2021 | $18.00 | Buy | Colliers Securities |
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2024 fourth quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2024 fourth quarter cash dividend of $0.21 per share of common stock and unit, which will be paid January 8, 2025 to common stockholders and unitholders of record as of December 20, 2024. Series A Preferred Dividend The Board has also declared a quarterly
Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and nine months ended September 30, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the third quarter, we continued to deliver steady results while actively engaging in the transaction market to accretively grow our high-quality portfolio. I'm
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
10-Q - Global Medical REIT Inc. (0001533615) (Filer)
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00
Robert W. Baird downgraded Global Medical REIT from Outperform to Neutral and set a new price target of $9.00
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2024 fourth quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2024 fourth quarter cash dividend of $0.21 per share of common stock and unit, which will be paid January 8, 2025 to common stockholders and unitholders of record as of December 20, 2024. Series A Preferred Dividend The Board has also declared a quarterly
Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and nine months ended September 30, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the third quarter, we continued to deliver steady results while actively engaging in the transaction market to accretively grow our high-quality portfolio. I'm
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its third quarter 2024 financial results after the market closes on Wednesday, November 6, 2024. The Company intends to hold a conference call to discuss those results the following day, Thursday, November 7, 2024, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief Investment O